cull – Talk Bio

Actionable Insights Powered by AI

Incyte’s $750M Acquisition Hits Roadblock: Key Trial Paused and Asset Cull Announced

Incyte, $750M buyout, paused trial, asset cull, biotech news, pharmaceutical industry